Dr. Sandra India Aldana is a researcher in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai. She holds an MPH in Environmental Health Sciences with a certificate in Applied Biostatistics from Columbia University and an MPhil and PhD in Epidemiology from NYU. Her research has primarily focused on how environmental exposures influence obesity and metabolic outcomes, including obesity-related cancer, type 2 diabetes, liver injury, and related metabolic biomarkers. Dr. India Aldana studies the “exposome” from a conjunctive standpoint across different disciplines with chemical and dietary origins and social attributes. She has expertise in investigating 1) built environment factors (i.e. neighborhood walkability, land use mix, and food environment), and 2) exposures to endocrine-disrupting chemicals or EDCs (i.e. air pollution, PFAS, fluoride, pesticides) during sensitive windows throughout the life-span leveraging populations such as pregnant women, postmenopausal women, and children in the US and abroad. As part of her NIEHS K99/R00 Award, she currently specializes in cardiometabolic diseases in adult women by studying metabolic syndrome, a cluster of conditions that increase cardiometabolic risk, while integrating methods grounded in exposure-mixture analysis with metabolomic mediation. To date, she has authored high-impact articles published in top environmental health and clinical journals such as ES&T, EHP, Environ Int, or J Hepatology.
Dr. Sandra India Aldana is a researcher in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai. She holds an MPH in Environmental Health Sciences with a certificate in Applied Biostatistics from Columbia University and an MPhil and PhD in Epidemiology from NYU. Her research has primarily focused on how environmental exposures influence obesity and metabolic outcomes, including obesity-related cancer, type 2 diabetes, liver injury, and related metabolic biomarkers. Dr. India Aldana studies the “exposome” from a conjunctive standpoint across different disciplines with chemical and dietary origins and social attributes. She has expertise in investigating 1) built environment factors (i.e. neighborhood walkability, land use mix, and food environment), and 2) exposures to endocrine-disrupting chemicals or EDCs (i.e. air pollution, PFAS, fluoride, pesticides) during sensitive windows throughout the life-span leveraging populations such as pregnant women, postmenopausal women, and children in the US and abroad. As part of her NIEHS K99/R00 Award, she currently specializes in cardiometabolic diseases in adult women by studying metabolic syndrome, a cluster of conditions that increase cardiometabolic risk, while integrating methods grounded in exposure-mixture analysis with metabolomic mediation. To date, she has authored high-impact articles published in top environmental health and clinical journals such as ES&T, EHP, Environ Int, or J Hepatology.